Literature DB >> 15815866

Treatment of proximal humeral fractures with a new intramedullary nail.

Kazuya Tamai1, Wataru Ohno, Michio Takemura, Hirotaka Mashitori, Jun'ichiro Hamada, Koichi Saotome.   

Abstract

We have developed a new intramedullary nail (All-in-One Nail) that is specifically designed for elastic fixation of a surgical neck fracture of the humerus. This nail has three pins and a plate, and the pins become divergent as the nail is inserted into the marrow cavity through the deltoid tuberosity and then advanced to the humeral head. We reviewed 31 patients with an age range of 58-91 years (mean 75 years) who underwent surgery with this nail for A3.2 (two-part), B2.2 (three-part), or C2.1 (valgus-impacted) fractures of the proximal humerus. Bony union was obtained in 29 patients, and these patients had a Japanese Orthopaedic Association shoulder score of 60-92 (mean 78) in a follow-up examination performed 6-32 months (mean 13 months) postoperatively. The All-in-One Nail system is easy to use, provides an acceptable clinical outcome, and is a treatment option for unimpacted surgical neck fractures and valgus-impacted fractures of the humerus.

Entities:  

Mesh:

Year:  2005        PMID: 15815866     DOI: 10.1007/s00776-004-0879-z

Source DB:  PubMed          Journal:  J Orthop Sci        ISSN: 0949-2658            Impact factor:   1.601


  3 in total

1.  PHN for treatment of proximal humerus fractures: evaluation of 80 cases.

Authors:  Claudio Iacobellis; Damiano Serafini; Roberto Aldegheri
Journal:  Chir Organi Mov       Date:  2009-05-26

2.  A new approach for the treatment of proximal humeral fractures using the TRIGEN proximal humeral nail.

Authors:  Qing-he Liu; Wei Sun; Jun-lin Zhou; Xiao-bao Ren; Tie Lu; Lei Shan; Yang Liu
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-05-21

3.  Is locking nailing of humeral head fractures superior to locking plate fixation?

Authors:  G Gradl; A Dietze; M Kääb; W Hopfenmüller; T Mittlmeier
Journal:  Clin Orthop Relat Res       Date:  2009-06-13       Impact factor: 4.176

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.